Cargando…
Effects of biological therapies on chronic rhinosinusitis in severe asthmatic patients
OBJECTIVE: The introduction of monoclonal antibody (mAb) therapies represents a promising treatment for refractory chronic rhinosinusitis (CRS). We assessed the effects of selected mAbs (omalizumab, mepolizumab, benralizumab) on CRS in severe asthmatic patients in a real-life setting. METHODS: A pro...
Autores principales: | Bandi, Francesco, Gallo, Stefania, Preti, Andrea, Mozzanica, Francesco, Visca, Dina, Marelli, Margherita, Maddalone, Enrico, Gambarini, Cinzia, Vaghi, Adriano, Spanevello, Antonio, Castelnuovo, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore Srl
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889250/ https://www.ncbi.nlm.nih.gov/pubmed/33558772 http://dx.doi.org/10.14639/0392-100X-N0716 |
Ejemplares similares
-
Prognostic value of the Sinonasal Outcome Test 22 (SNOT-22) in chronic rhinosinusitis
por: Gallo, Stefania, et al.
Publicado: (2020) -
Exploring the role of nasal cytology in chronic rhinosinusitis
por: Gallo, Stefania, et al.
Publicado: (2020) -
Multiple gene expression profiling suggests epithelial dysfunction in polypoid chronic rhinosinusitis
por: PISTOCHINI, A., et al.
Publicado: (2019) -
Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics
por: De Corso, Eugenio, et al.
Publicado: (2023) -
Italian version of the Brief Questionnaire of Olfactory Disorders (Brief-IT-QOD)
por: Cardella, Arianna, et al.
Publicado: (2023)